Editas Medicine (EDIT) gains 0.16% for October 21


Editas Medicine Inc (NASDAQ: EDIT) shares gained 0.16%, or $0.06 per share, to close Thursday at $38.47. After opening the day at $38.49, shares of Editas Medicine fluctuated between $39.70 and $38.40. 843,392 shares traded hands a decrease from their 30 day average of 2,129,395. Thursday’s activity brought Editas Medicine’s market cap to $2,626,010,480.


Editas Medicine is headquartered in Cambridge, Massachusetts..

About Editas Medicine Inc

As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.



Visit Editas Medicine Inc’s profile for more information.



The Daily Fix



Here’s a trending selection from our newsletter, The Daily Fix, that captured readers’ attention. Click here to subscribe and get The Daily Fix delivered right to your inbox.



Breaking the Supply Chain Bottleneck



Since the start of the global pandemic, historically low interest rates and government spending have inhibited saving and encouraged borrowing and spending to lift the economy during the challenging period. The US Federal Reserve and government have pumped far more liquidity into the financial system than during the 2008 global financial crisis. We have seen an increase in inflationary pressures because of the stimulus. Moreover, the pandemic’s unintended consequences have created shortages and supply chain bottlenecks that have only exacerbated rising prices.



[More]




McDonald’s To Offer New Plant-Based Burger in US Restaurants by Beyond Meat



McDonald’s Corporation (NYSE: MCD) will soon launch a small-scale rollout in the US of a new plant-based burger developed with faux-meat maker Beyond Meat Inc (Nasdaq:  BYND).



Starting Nov. 3, the “McPlant” will be on the menu at eight locations in Texas, Louisiana, Iowa and California as part of a trial run to help gauge customer interest in the meatless offering, McDonald’s announced last week.



[More]




 


Walgreens Investing Additional $5.2 Billion in Primary Care Provider VillageMD



Walgreens Boots Alliance Inc (Nasdaq: WBA) will invest $5.2 billion in primary care provider VillageMD as part of the pharmacy chain’s plan to open more co-located practices within its drugstores across the US.



The investment announced Thursday increases the Deerfield, Illinois-based chain’s stake in VillageMD to 63% from the 30% it acquired in July 2020. 



[More]






About The Nasdaq Stock Market





The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world’s leading exchange for options volume and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.



To get more information on Editas Medicine Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Editas Medicine Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.



Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: www.equities.com/disclaimer


Jobless Claims Fall to 290,000 — 19-Month Low
Paul Tudor Jones Calls Inflation ‘Single Biggest Threat’ to Financial Markets
FDA Expands Booster Dose Usage Authorization for COVID-19 Vaccines
McDonald’s To Offer New Plant-Based Burger in US Restaurants by Beyond Meat
Walgreens Investing Additional $5.2 Billion in Primary Care Provider VillageMD
JPMorgan Misses on Third Quarter Revenue, Beats Earnings Estimates With One-Time Items
BlackRock Beats Q3 Profit Estimates, But Asset Growth Flattens
Emerson Electric To Merge Industrial Software Businesses With Aspen Technology


Read more here: Source link